Dementia cases to double by 2030: WHO

April 11, 2012 by Lucy Christie in Alzheimer's disease & dementia

The number of people with dementia is expected to almost double to 65.7 million by 2030 as the world population ages, according to a World Health Organisation report published Wednesday.

And by 2050 the number of sufferers could be more than three times the current figure of 35.6 million, the UN body said.

The report released by WHO and Alzheimer's Disease International estimates the current cost of treating and caring for those with the condition at $604 billion (461 billion euros) a year.

Dementia is caused by a variety of brain illnesses that affect memory, thinking, behaviour and the ability to perform everyday activities.

Alzheimer's disease is the most common cause of dementia and accounts for about 70 percent of cases.

More than half of sufferers (58%) live in low and middle income countries but this could rise to 70 percent by 2050.

The report said far more effective diagnosis was needed, as even in high income countries only 20 to 50 percent of dementia cases are routinely recognised.

"Since we know the prevelence of the disease will explode in this century as we all live longer -- the risk of dementia is 1 in 8 for those over 65 and a shocking 1 in 2.5 for those over 85 -- its impact will become greater as the decades go by," according to Shekhar Saxena, head of the mental health department at WHO.

"We need to increase our capacity to detect dementia early and to provide the necessary health and social care," said Oleg Chestnov, assistant director general of Noncommunicable Diseases and Mental Health at WHO.

"Much can be done to decrease the burden of dementia. Health-care workers are often not adequately trained to recognise dementia."

Only eight countries worldwide -- Australia, Britain, Denmark, France, Japan, South Korea, the Netherlands and Norway -- currently have national programmes in place to address dementia, according to the report "Dementia: a public health priority".

Germany and Sweden have set out lists of recommendations.

The study also highlights a general lack of information and understanding about the disease, fuelling stigma with the result that people sometimes delay seeking support.

"It is now vital to tackle the poor levels of public awareness and understanding, and to drastically reduce the stigma associated with dementia," said Marc Wortmann, executive director of Alzheimer's Disease International.

"We need to act, we need to stop this epidemic."

In its report, the WHO recommends that authorities seek to reduce the stigma that has long been associated with dementia, and improve general care for victims, along with support for caregivers.

It is currently not possible to treat dementia, but progress of the disease can in some cases be slowed down.

(c) 2012 AFP

not rated yet  

Rank not rated yet
Relevant PhysicsForums posts

More news stories

Scientists identify molecular trigger for Alzheimer's disease

Researchers have pinpointed a catalytic trigger for the onset of Alzheimer's disease – when the fundamental structure of a protein molecule changes to cause a chain reaction that leads to the death of neurons ...

Alzheimer's disease & dementia created 8 hours ago | popularity 5 / 5 (2) | comments 0 | with audio podcast

Study finds that sleep apnea and Alzheimer's are linked

A new study looking at sleep-disordered breathing (SDB) and markers for Alzheimer's disease (AD) risk in cerebrospinal fluid (CSF) and neuroimaging adds to the growing body of research linking the two.

Alzheimer's disease & dementia created May 19, 2013 | popularity 5 / 5 (3) | comments 0 | with audio podcast

Alzheimer's leaves bilingual victims stranded in Canada

The devastating effect of Alzheimer's disease on bilingual people has been thrown into focus in Canada, where the sudden loss of a second language can leave sufferers feeling like strangers in their own country.

Alzheimer's disease & dementia created May 19, 2013 | popularity not rated yet | comments 0

Study identifies new approach to improving treatment for MS and other conditions

(Medical Xpress)—Working with lab mice models of multiple sclerosis (MS), UC Davis scientists have detected a novel molecular target for the design of drugs that could be safer and more effective than current FDA-approved ...

Alzheimer's disease & dementia created May 17, 2013 | popularity 5 / 5 (2) | comments 0 | with audio podcast

Nonmelanoma skin cancer tied to lower Alzheimer's risk

(HealthDay)—Older individuals with nonmelanoma skin cancer (NMSC) seem to have a significantly reduced risk of developing Alzheimer's disease (AD), according to a study published online May 15 in Neurology.

Alzheimer's disease & dementia created May 16, 2013 | popularity 5 / 5 (1) | comments 0


The compound in the Mediterranean diet that makes cancer cells 'mortal'

New research suggests that a compound abundant in the Mediterranean diet takes away cancer cells' "superpower" to escape death. By altering a very specific step in gene regulation, this compound essentially re-educates cancer ...

Do salamanders hold the solution to regeneration?

Salamanders' immune systems are key to their remarkable ability to regrow limbs, and could also underpin their ability to regenerate spinal cords, brain tissue and even parts of their hearts, scientists have ...

Practice makes perfect? Not so much

Turns out, that old "practice makes perfect" adage may be overblown. New research led by Michigan State University's Zach Hambrick finds that a copious amount of practice is not enough to explain why people ...

Older prostate cancer patients should think twice before undergoing treatment

Older prostate cancer patients with other underlying health conditions should think twice before committing to surgery or radiation therapy for their cancer, according to a multicenter study led by researchers in the UCLA ...

New test better detects elephantiasis worm infection

A new diagnostic test for a worm infection that can lead to severe enlargement and deformities of the legs and genitals is far more sensitive than the currently used test, according to results of a field ...

Researchers develop model for better testing, targeting of malignant peripheral nerve sheath tumors

University of Minnesota Medical School researchers from the Masonic Cancer Center, University of Minnesota, in partnership with the University's Brain Tumor Program, have developed a new mouse model of malignant peripheral ...